Retroviral vector-mediated gene transfer into umbilical cord blood CD34brCD38−CD33− cells
- 1 August 1999
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 27 (8) , 1244-1254
- https://doi.org/10.1016/s0301-472x(99)00065-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Retrovirus-Mediated Gene Transfer into Human CD34+38lowPrimitive Cells Capable of Reconstituting Long-Term CulturesIn Vitroand Nonobese Diabetic–Severe Combined Immunodeficiency MiceIn VivoHuman Gene Therapy, 1998
- High‐resolution cell division tracking demonstrates the Flt3‐ligand‐dependence of human marrow CD34+CD38− cell production in vitroBritish Journal of Haematology, 1997
- Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapyNature Medicine, 1996
- Cell–surface markers for assessing gene transfer into human hematopoietic cellsNature Medicine, 1996
- Gene Transfer to Hematopoietic CellsNew England Journal of Medicine, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA − Immunodeficient PatientsScience, 1995
- Gene transfer into hematopoietic progenitor and stem cells: Progress and problemsThe International Journal of Cell Cloning, 1994
- High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood.The Journal of Experimental Medicine, 1993
- Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties.The Journal of Experimental Medicine, 1989